FDG imaging of spinal cord primitive neuroectodermal tumor

Journal of Nuclear Medicine

Volumn 39, Issue 7, 1998, Pages 1207-1209

  Meltzer, Carolyn Cidis ^a   Townsend, David W ^b   Kottapally, Sri ^b   Jadali, Faydah ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b NONE

Author keywords

Neoplasms; PET; Primitive neuroectodermal tumor; Spinal cord

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; BRAIN METABOLISM; CASE REPORT; CERVICAL SPINAL CORD; CLINICAL PROTOCOL; GRAY MATTER; HUMAN; HUMAN TISSUE; MALE; NEUROECTODERM TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SPINAL CORD TUMOR;

ADULT; FEASIBILITY STUDIES; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEUROECTODERMAL TUMORS, PRIMITIVE; RADIOPHARMACEUTICALS; SPINAL CORD NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0042259692     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ishikawa M, Kikuchi H, Miyalake S, Oda Y, Yonekura Y, Nichizawa S. Glucose consumption in recurrent gliomas. Neurosurgery 1993;33:28-33.
2. Patronas NJ, Di Chiro G, Kufta C, et al. Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 1985;62:816-822.
3. Alavi JB, Alavi A, Chawluk J, et al. Positron emission tomography in patients with glioma. A predictor of prognosis. Cancer 1988;62:1074-1078.
4. Hoffman JM, Lowe VJ, Brown M, Burger P, Hanson MW, Coleman RE. The prognostic and diagnostic usefulness of FDG-PET in primary brain tumor management [Abstract]. J Nucl Med 1993;34:37P.
5. Mineura K, Sasajima T, Kowada M, et al. Perfusion and metabolism in predicting the survival of patients with cerebral gliomas. Cancer 1994;73:2386-2394.
6. Rosenfeld SS, Hoffman JM, Coleman RE, Glantz MJ, Hanson MW, Schold SC. Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxy-glucose positron emission tomography. J Nucl Med 1992;33:532-536.
7. 18F-FDG uptake in primary cerebral lymphoma: a PET study. J Comput Assist Tomogr 1988;12:47-48.
8. Di Chiro G, Hatazawa J, Katz DA, Rizzoli HV, De Michele DJ. Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study. Radiology 1987;164:521-526.
9. Holthoff VA, Herholz K, Berthold F, et al. In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal tumors before and after treatment. Cancer 1993;72:1394-403.
10. Griffeth LK, Rich KM, Dehdashti F, et al. Brain metastases from non-central nervous system tumors: evaluation with PET. Radiology 1993;186:37-44.
11. 18F-2-deoxyglucose in normal and pathological cases. J Comput Assist Tomogr 1983;7:937-945.
12. 11C-methyl)-L-methionine. Neuroradiology 1996;38:53-55.
13. 82Rb positron emission tomography. J Comput Assist Tomogr 1987;11:563-570.
14. 18F-fluorodeoxyglucose positron emission tomography. Ann Neurol 1991;29:347-355.
15. Hoffman EJ, Huang SC, Phelps ME. Quantitation in positron emission CT: 1. Effect of object size. J Comput Assist Tomogr 1979;3:299-308.
16. Kessler RM, Ellis JR, Eden M. Analysis of emission tomographic scan data: limitations imposed by resolution and background. J Comput Assist Tomogr 1984;8: 514-522.
17. Mazziotta JC, Phelps ME, Plummer D, Kuhl DE. Quantitation in positron emission tomography: 5. Physical-anatomical effects. J Comput Assist Tomogr 1981;5:734-743.
18. Dooms GC, Hecht S, Brant-Zawadski M, Berthiaume Y, Norman D, Newton TH. Brain radiation lesions: MR imaging. Radiology 1986;158:149-155.